Does the media prefer BLLN or FMS?

In the previous week, Billiontoone and Billiontoone both had 2 articles in the media. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.27 beat Billiontoone's score of 0.00 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Billiontoone 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Fresenius Medical Care AG & Co. KGaA 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to BLLN or BTSG?

In the previous week, BrightSpring Health Services had 6 more articles in the media than Billiontoone. MarketBeat recorded 8 mentions for BrightSpring Health Services and 2 mentions for Billiontoone. BrightSpring Health Services' average media sentiment score of 1.07 beat Billiontoone's score of 0.00 indicating that BrightSpring Health Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Billiontoone 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral BrightSpring Health Services 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings & valuation, BLLN or DVA?

DaVita has higher revenue and earnings than Billiontoone. DaVita is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Billiontoone $305.11M 14.96 $7.45M $0.70 138.20 DaVita $14.01B 0.80 $746.80M $12.22 14.45

Is BLLN or DVA more profitable?

Billiontoone has a net margin of 8.04% compared to DaVita's net margin of 6.05%. Billiontoone's return on equity of 9.96% beat DaVita's return on equity. Company Net Margins Return on Equity Return on Assets Billiontoone 8.04% 9.96% 5.35% DaVita 6.05% -217.63% 5.07%

Does the media refer more to BLLN or DVA?

In the previous week, DaVita had 8 more articles in the media than Billiontoone. MarketBeat recorded 10 mentions for DaVita and 2 mentions for Billiontoone. DaVita's average media sentiment score of 1.79 beat Billiontoone's score of 0.00 indicating that DaVita is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Billiontoone 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral DaVita 10 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Is BLLN or TEM more profitable?

Billiontoone has a net margin of 8.04% compared to Tempus AI's net margin of -17.77%. Billiontoone's return on equity of 9.96% beat Tempus AI's return on equity. Company Net Margins Return on Equity Return on Assets Billiontoone 8.04% 9.96% 5.35% Tempus AI -17.77% -50.28% -10.33%

Does the media prefer BLLN or TEM?

In the previous week, Tempus AI had 50 more articles in the media than Billiontoone. MarketBeat recorded 52 mentions for Tempus AI and 2 mentions for Billiontoone. Tempus AI's average media sentiment score of 0.57 beat Billiontoone's score of 0.00 indicating that Tempus AI is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Billiontoone 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Tempus AI 27 Very Positive mention(s) 4 Positive mention(s) 10 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation and earnings, CHE or BLLN?

Chemed has higher revenue and earnings than Billiontoone. Chemed is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Chemed $2.60B 2.72 $265.24M $19.91 27.13 Billiontoone $305.11M 14.96 $7.45M $0.70 138.20

Is CHE or BLLN more profitable?

Chemed has a net margin of 10.60% compared to Billiontoone's net margin of 8.04%. Chemed's return on equity of 31.77% beat Billiontoone's return on equity. Company Net Margins Return on Equity Return on Assets Chemed 10.60% 31.77% 18.90% Billiontoone 8.04% 9.96% 5.35%

Does the media refer more to CHE or BLLN?

In the previous week, Chemed had 9 more articles in the media than Billiontoone. MarketBeat recorded 11 mentions for Chemed and 2 mentions for Billiontoone. Chemed's average media sentiment score of 1.42 beat Billiontoone's score of 0.00 indicating that Chemed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Chemed 8 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Billiontoone 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Billiontoone (BLLN) Competitors

$96.74 +1.71 (+1.80%)

Closing price 04:00 PM Eastern

Extended Trading

$95.35 -1.39 (-1.44%)

As of 07:10 PM Eastern

Compare

BLLN vs. FMS, BTSG, DVA, TEM, and CHE

Should you buy Billiontoone stock or one of its competitors? Billiontoone's main competitors and comparable companies include Fresenius Medical Care AG & Co. KGaA (FMS), BrightSpring Health Services (BTSG), DaVita (DVA), Tempus AI (TEM), and Chemed (CHE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Billiontoone compare to Fresenius Medical Care AG & Co. KGaA?

Billiontoone (NASDAQ:BLLN) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings.

Billiontoone presently has a consensus target price of $126.71, suggesting a potential upside of 30.98%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $23.57, suggesting a potential upside of 0.26%. Given Billiontoone's stronger consensus rating and higher possible upside, equities research analysts plainly believe Billiontoone is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.55

In the previous week, Billiontoone and Billiontoone both had 2 articles in the media. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.27 beat Billiontoone's score of 0.00 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Billiontoone	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Fresenius Medical Care AG & Co. KGaA	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Billiontoone. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Billiontoone	$305.11M	14.96	$7.45M	$0.70	138.20
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.57	$1.11B	$1.93	12.18

8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 50.2% of Billiontoone shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Billiontoone has a net margin of 8.04% compared to Fresenius Medical Care AG & Co. KGaA's net margin of 4.83%. Billiontoone's return on equity of 9.96% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Billiontoone	8.04%	9.96%	5.35%
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%

Summary

Billiontoone beats Fresenius Medical Care AG & Co. KGaA on 9 of the 14 factors compared between the two stocks.

How does Billiontoone compare to BrightSpring Health Services?

Billiontoone (NASDAQ:BLLN) and BrightSpring Health Services (NASDAQ:BTSG) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, valuation, institutional ownership, profitability and risk.

Billiontoone currently has a consensus price target of $126.71, suggesting a potential upside of 30.98%. BrightSpring Health Services has a consensus price target of $70.71, suggesting a potential upside of 18.85%. Given Billiontoone's higher probable upside, equities research analysts plainly believe Billiontoone is more favorable than BrightSpring Health Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	3.10

In the previous week, BrightSpring Health Services had 6 more articles in the media than Billiontoone. MarketBeat recorded 8 mentions for BrightSpring Health Services and 2 mentions for Billiontoone. BrightSpring Health Services' average media sentiment score of 1.07 beat Billiontoone's score of 0.00 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Billiontoone	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
BrightSpring Health Services	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Billiontoone has a net margin of 8.04% compared to BrightSpring Health Services' net margin of 2.55%. BrightSpring Health Services' return on equity of 16.73% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Billiontoone	8.04%	9.96%	5.35%
BrightSpring Health Services	2.55%	16.73%	5.24%

BrightSpring Health Services has higher revenue and earnings than Billiontoone. BrightSpring Health Services is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Billiontoone	$305.11M	14.96	$7.45M	$0.70	138.20
BrightSpring Health Services	$14.37B	0.82	$190.67M	$1.66	35.84

Summary

BrightSpring Health Services beats Billiontoone on 9 of the 14 factors compared between the two stocks.

How does Billiontoone compare to DaVita?

Billiontoone (NASDAQ:BLLN) and DaVita (NYSE:DVA) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, valuation, analyst recommendations, profitability, earnings and risk.

DaVita has higher revenue and earnings than Billiontoone. DaVita is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Billiontoone	$305.11M	14.96	$7.45M	$0.70	138.20
DaVita	$14.01B	0.80	$746.80M	$12.22	14.45

90.1% of DaVita shares are held by institutional investors. 50.2% of Billiontoone shares are held by insiders. Comparatively, 1.9% of DaVita shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, DaVita had 8 more articles in the media than Billiontoone. MarketBeat recorded 10 mentions for DaVita and 2 mentions for Billiontoone. DaVita's average media sentiment score of 1.79 beat Billiontoone's score of 0.00 indicating that DaVita is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Billiontoone	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
DaVita	10 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Billiontoone currently has a consensus price target of $126.71, indicating a potential upside of 30.98%. DaVita has a consensus price target of $221.75, indicating a potential upside of 25.61%. Given Billiontoone's stronger consensus rating and higher possible upside, equities analysts plainly believe Billiontoone is more favorable than DaVita.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
DaVita	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.38

Billiontoone has a net margin of 8.04% compared to DaVita's net margin of 6.05%. Billiontoone's return on equity of 9.96% beat DaVita's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Billiontoone	8.04%	9.96%	5.35%
DaVita	6.05%	-217.63%	5.07%

Summary

Billiontoone beats DaVita on 9 of the 15 factors compared between the two stocks.

How does Billiontoone compare to Tempus AI?

Billiontoone (NASDAQ:BLLN) and Tempus AI (NASDAQ:TEM) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, media sentiment, dividends, institutional ownership, analyst recommendations, profitability and earnings.

Billiontoone presently has a consensus target price of $126.71, suggesting a potential upside of 30.98%. Tempus AI has a consensus target price of $65.69, suggesting a potential downside of 0.72%. Given Billiontoone's stronger consensus rating and higher probable upside, analysts plainly believe Billiontoone is more favorable than Tempus AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
Tempus AI	2 Sell rating(s)	6 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.41

24.2% of Tempus AI shares are held by institutional investors. 50.2% of Billiontoone shares are held by insiders. Comparatively, 24.3% of Tempus AI shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Tempus AI had 50 more articles in the media than Billiontoone. MarketBeat recorded 52 mentions for Tempus AI and 2 mentions for Billiontoone. Tempus AI's average media sentiment score of 0.57 beat Billiontoone's score of 0.00 indicating that Tempus AI is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Billiontoone	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Tempus AI	27 Very Positive mention(s)	4 Positive mention(s)	10 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Billiontoone has higher earnings, but lower revenue than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Billiontoone	$305.11M	14.96	$7.45M	$0.70	138.20
Tempus AI	$1.27B	9.39	-$245.03M	-$1.44	N/A

Billiontoone has a net margin of 8.04% compared to Tempus AI's net margin of -17.77%. Billiontoone's return on equity of 9.96% beat Tempus AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Billiontoone	8.04%	9.96%	5.35%
Tempus AI	-17.77%	-50.28%	-10.33%

Summary

Billiontoone beats Tempus AI on 10 of the 15 factors compared between the two stocks.

How does Billiontoone compare to Chemed?

Chemed (NYSE:CHE) and Billiontoone (NASDAQ:BLLN) are both mid-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, profitability, analyst recommendations, risk and valuation.

95.8% of Chemed shares are owned by institutional investors. 3.3% of Chemed shares are owned by insiders. Comparatively, 50.2% of Billiontoone shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Chemed had 9 more articles in the media than Billiontoone. MarketBeat recorded 11 mentions for Chemed and 2 mentions for Billiontoone. Chemed's average media sentiment score of 1.42 beat Billiontoone's score of 0.00 indicating that Chemed is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Chemed	8 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Billiontoone	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Chemed currently has a consensus price target of $530.75, indicating a potential downside of 1.75%. Billiontoone has a consensus price target of $126.71, indicating a potential upside of 30.98%. Given Billiontoone's stronger consensus rating and higher probable upside, analysts clearly believe Billiontoone is more favorable than Chemed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemed	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50

Chemed has higher revenue and earnings than Billiontoone. Chemed is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chemed	$2.60B	2.72	$265.24M	$19.91	27.13
Billiontoone	$305.11M	14.96	$7.45M	$0.70	138.20

Chemed has a net margin of 10.60% compared to Billiontoone's net margin of 8.04%. Chemed's return on equity of 31.77% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chemed	10.60%	31.77%	18.90%
Billiontoone	8.04%	9.96%	5.35%

Summary

Chemed beats Billiontoone on 9 of the 15 factors compared between the two stocks.

Get Billiontoone News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BLLN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BLLN vs. The Competition

Export

Metric	Billiontoone	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$4.57B	$9.92B	$7.29B	$12.71B
Dividend Yield	N/A	2.55%	2.54%	10.79%
P/E Ratio	138.20	34.42	271.38	24.10
Price / Sales	14.96	4.82	638.95	90.12
Price / Cash	293.59	24.64	29.03	36.90
Price / Book	9.23	5.37	11.18	6.40
Net Income	$7.45M	$309.96M	$3.46B	$348.28M
7 Day Performance	3.01%	0.13%	1.98%	0.91%
1 Month Performance	-23.27%	1.43%	7.32%	5.10%
1 Year Performance	N/A	15.25%	24.76%	16.16%

Billiontoone Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BLLN Billiontoone	4.1377 of 5 stars	$96.74 +1.8%	$126.71 +31.0%	N/A	$4.57B	$305.11M	138.20	620
FMS Fresenius Medical Care AG & Co. KGaA	3.1475 of 5 stars	$23.75 +0.5%	$23.57 -0.8%	-8.4%	$12.69B	$22.20B	12.31	1,488	Positive News
BTSG BrightSpring Health Services	4.9645 of 5 stars	$61.71 +2.5%	$70.71 +14.6%	+136.7%	$12.21B	$14.37B	37.17	23,500	Positive News Analyst Downgrade
DVA DaVita	4.8943 of 5 stars	$180.14 +0.5%	$221.75 +23.1%	+24.2%	$11.49B	$14.01B	14.74	78,000	Positive News
TEM Tempus AI	1.5652 of 5 stars	$52.10 -4.0%	$64.92 +24.6%	-9.7%	$9.80B	$1.27B	N/A	3,800	Trending News Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BLLN) was last updated on 8/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Billiontoone (BLLN) Competitors

BLLN vs. FMS, BTSG, DVA, TEM, and CHE

How does Billiontoone compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does Billiontoone compare to BrightSpring Health Services?

Summary

How does Billiontoone compare to DaVita?

Summary

How does Billiontoone compare to Tempus AI?

Summary

How does Billiontoone compare to Chemed?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BLLN vs. The Competition

Billiontoone Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Billiontoone (BLLN) Competitors

BLLN vs. FMS, BTSG, DVA, TEM, and CHE

How does Billiontoone compare to Fresenius Medical Care AG & Co. KGaA?

Do analysts rate BLLN or FMS?

Does the media prefer BLLN or FMS?

Which has preferable earnings and valuation, BLLN or FMS?

Do institutionals and insiders hold more shares of BLLN or FMS?

Is BLLN or FMS more profitable?

Summary

How does Billiontoone compare to BrightSpring Health Services?

Do analysts prefer BLLN or BTSG?

Does the media refer more to BLLN or BTSG?

Is BLLN or BTSG more profitable?

Which has preferable valuation & earnings, BLLN or BTSG?

Summary

How does Billiontoone compare to DaVita?

Which has preferable earnings & valuation, BLLN or DVA?

Do insiders and institutionals have more ownership in BLLN or DVA?

Does the media refer more to BLLN or DVA?

Do analysts recommend BLLN or DVA?

Is BLLN or DVA more profitable?

Summary

How does Billiontoone compare to Tempus AI?

Do analysts recommend BLLN or TEM?

Do insiders & institutionals have more ownership in BLLN or TEM?

Does the media prefer BLLN or TEM?

Which has higher earnings and valuation, BLLN or TEM?

Is BLLN or TEM more profitable?

Summary

How does Billiontoone compare to Chemed?

Do insiders and institutionals have more ownership in CHE or BLLN?

Does the media refer more to CHE or BLLN?

Do analysts recommend CHE or BLLN?

Which has better valuation and earnings, CHE or BLLN?

Is CHE or BLLN more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BLLN vs. The Competition

Billiontoone Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools